Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical and radiobiological consideration of cyclical hypofractionated radiation therapy also known as QUAD Shot for neglected skin cancer disfiguring the face of a non-compliant patient who was refusing surgery and protracted radiation therapy: case report

  • Received : 2019.05.13
  • Accepted : 2019.06.04
  • Published : 2019.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Although surgery is the mainstay of local treatment for skin cancer, definitive radiation therapy (RT) has been also applied for patients who are unable to tolerate surgery. Definitive RT regimens usually consist of daily treatment for 4-7 weeks. Such protracted daily RT regimens, however, would not be feasible for non-compliant patients or patients who are unable to make multiple daily trips for weeks. Without treatment, however, skin cancers can continuously progress and cause distressing symptoms. A cyclical hypofractionated RT (QUAD Shot: 14 Gy in 4 fractions, twice-daily treatments with 6 hours interval on 2 consecutive days) can be a practical RT regimen for those patients. In this report, we present the successful treatment course of repeated QUAD Shots in a 79-year-old patient with neglected skin cancer that was disfiguring his face yet declined definitive surgery and protracted RT. We also evaluated and compared biologically equivalent doses between QUAD Shots and conventionally fractionated protracted RT regimens.

Keywords

References

  1. Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010;146:279-82. https://doi.org/10.1001/archdermatol.2010.4
  2. Rubio-Casadevall J, Hernandez-Pujol AM, Ferreira-Santos MC, et al. Trends in incidence and survival analysis in nonmelanoma skin cancer from 1994 to 2012 in Girona, Spain: a population-based study. Cancer Epidemiol 2016;45:6-10. https://doi.org/10.1016/j.canep.2016.09.001
  3. Xiang F, Lucas R, Hales S, Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. JAMA Dermatol 2014;150:1063-71. https://doi.org/10.1001/jamadermatol.2014.762
  4. Wassberg C, Thorn M, Johansson AM, Bergstrom R, Berne B, Ringborg U. Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol 2001;81:268-72. https://doi.org/10.1080/00015550152572903
  5. Hemminki K, Zhang H, Czene K. Time trends and familial risks in squamous cell carcinoma of the skin. Arch Dermatol 2003;139:885-9. https://doi.org/10.1001/archderm.139.7.885
  6. Eisemann N, Jansen L, Castro FA, et al. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol 2016;174:778-85. https://doi.org/10.1111/bjd.14352
  7. Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013;149:541-7. https://doi.org/10.1001/jamadermatol.2013.2139
  8. Hernandez-Machin B, Borrego L, Gil-Garcia M, Hernandez BH. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 2007;46:453-9. https://doi.org/10.1111/j.1365-4632.2006.03108.x
  9. Grossi Marconi D, da Costa Resende B, Rauber E, et al. Head and neck non-melanoma skin cancer treated by superficial X-ray therapy: an analysis of 1021 cases. PLoS One 2016;11:e0156544. https://doi.org/10.1371/journal.pone.0156544
  10. National Comprehensive Cancer Network. NCCN Guidelines: squamous cell skin cancer [Internet]. Plymouth Meeting, PA: National Comprehensive Cancer Network; c2019 [cited 2019 May 30]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf.
  11. Kil WJ, Camphausen K. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities. Head Neck 2017;39:E55-E60. https://doi.org/10.1002/hed.24700
  12. Chen AM, Vaughan A, Narayan S, Vijayakumar S. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme. Head Neck 2008;30:1586-91. https://doi.org/10.1002/hed.20894
  13. Paris KJ, Spanos WJ Jr, Lindberg RD, Jose B, Albrink F. Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies. Int J Radiat Oncol Biol Phys 1993;25:657-60. https://doi.org/10.1016/0360-3016(93)90012-k
  14. Corry J, Peters LJ, Costa ID, et al. The 'QUAD SHOT': a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol 2005;77:137-42. https://doi.org/10.1016/j.radonc.2005.10.008
  15. Lok BH, Jiang G, Gutiontov S, et al. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. Oral Oncol 2015;51:957-62. https://doi.org/10.1016/j.oraloncology.2015.07.011

Cited by

  1. The Role of Postoperative Radiotherapy and Prognostic Model in Primary Squamous Cell Carcinoma of Parotid Gland vol.10, 2019, https://doi.org/10.3389/fonc.2020.618564
  2. Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot vol.10, pp.13, 2019, https://doi.org/10.1002/cam4.3646